ClinicalTrialStartPulse: United States sites
2,424 clinicalTrialStartPulse: United States sites are listed from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-09-24 to 2026-11-02; the most frequent is AstraZeneca with 27. Data last updated 2026-11-03; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Includes: Sponsor, Phase, Conditions, Enrollment, Countries, Event, Posted, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
2,424 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (the 500 newest are listed here), dated 2026-09-24 to 2026-11-02. Most frequent: AstraZeneca (27). Each record links to a full report and the official source.
Last updated 2026-11-03. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Get new ClinicalTrialStartPulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- AstraZeneca (27)
- Pfizer (23)
- Janssen Research & Development, LLC (21)
- Hoffmann-La Roche (15)
- Sanofi (13)
How do I get new clinicalTrialStartPulse: United States sites by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top clinicalTrialStartPulse: United States sites right now?
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| Idorsia Pharmaceuticals Ltd. | Phase 3 | Fabry Disease | 107 |
| Bristol-Myers Squibb | Phase 3 | Urothelial Cancer | 1314 |
| Hoffmann-La Roche | Phase 2 | Non-Hodgkins Lymphoma | 211 |
| Pfizer | Phase 2 | Obesity and Obesity-related Medical Conditions | 201 |
| AstraZeneca | Phase 2 | Carcinoma, Non-Small-Cell Lung | 103 |
| ArriVent BioPharma, Inc. | Phase 3 | Metastatic Non-Small Cell Lung Cancer; Advanced Non-Small Cell Lung Cancer; EGFR Exon 20 Mutations | 398 |
| Sanofi | Phase 2 | Type 1 Diabetes Mellitus | 197 |
| Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 621 |
| AstraZeneca | Phase 2 | Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer; Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer | 477 |
| Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 699 |
| Vaxcyte, Inc. | Phase 3 | Pneumococcal Disease | 1390 |
| Xilio Development, Inc. | Phase 2 | Metastatic NSCLC - Non-Small Cell Lung Cancer; Advanced Solid Tumor | 180 |
| Sanofi | Phase 2 | Ulcerative Colitis | 105 |
| Vertanical GmbH | Phase 3 | Lumbosacral Radiculopathy | 810 |
| TriGemX Bio, Inc. | Phase 3 | Migraine | 1500 |
| atai Therapeutics, Inc. | 🔒 Unlock all 500 records → | ||
| BeiGene | 🔒 Unlock all 500 records → | ||
| Pfizer | 🔒 Unlock all 500 records → | ||
Browse 35 more matching record reports
- atai Therapeutics, Inc.
- BeiGene
- Pfizer
- 35Pharma Inc., a GSK company
- Viatris Innovation GmbH
- Viatris Innovation GmbH
- EyeBiotech Ltd.
- Merck Sharp & Dohme LLC
- MedTrace Pharma A/S
- AstraZeneca
- Merck Sharp & Dohme LLC
- Pelage Pharmaceuticals, Inc.
- Uniquity One (UNI)
- Takeda
- AbbVie
- Uniquity One (UNI)
- AstraZeneca
- Eli Lilly and Company
- Carmot Therapeutics, Inc.
- AstraZeneca
- BioNTech SE
- Hoffmann-La Roche
- NS Pharma, Inc.
- Amgen
- GlaxoSmithKline
- Rapport Therapeutics Inc.
- Hoffmann-La Roche
- Multitude Therapeutics Inc.
- Shionogi
- ModernaTX, Inc.
- 4Moving Biotech
- Takeda
- Pfizer
- Pfizer
- Verrica Pharmaceuticals Inc.
Which related categories and locations should I check?
Browse by phase
Not applicable (device, behavioral) (4211) Observational (1999) Phase 2 (1077) Phase 3 (559) Phase 1 (546) Phase 4 (320) Early phase 1 (89)
Browse by site location
Browse by minimum enrollment
100+ (326) 50+ (283) 300+ (96) 1,000+ (54)
Frequently asked questions
How many clinicalTrialStartPulse: United States sites are listed?
2,424 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (the 500 newest are shown on this page), last refreshed automatically. The most recent is dated 2026-11-02.
Can I get alerts for United States sites?
Yes. ClinicalTrialStartPulse can email you new records matching this filter; plans are listed on the ClinicalTrialStartPulse page.
Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2. Informational only. RSS feed of new records